March 21, 2013
Free workshop on navigating FDA and other federal regulatory pathways offered
WEST LAFAYETTE, Ind. – The Purdue Office of Technology Commercialization is offering a free workshop on navigating the complex regulatory requirements for patenting and protecting intellectual property in the pharmaceutical drug and medical device sectors.
The program will be held Wednesday (March 27) from 11:30 a.m. to 1:30 p.m. in the Herman and Heddy Kurz Purdue Technology Center, 1281 Win Hentschel Blvd. West Lafayette.
Officials from Roche Diagnostics Operations Inc., Eli Lilly and Co. and Endocyte Inc. will lead a roundtable discussion on best practices for remaining apprised of continuing changes in the federal requirements to move medicinal and medical treatments through the commercialization process and to the public.
* Eric Kolodziej, senior vice president of global regulatory, Roche.
* Jeff Ferguson, senior research adviser, global regulatory, CMC Small Molecule, Lilly.
* Conrad Wong, adviser, regulatory affairs, early-phase clinical development, Lilly.
* Philip Low, chief science officer, Endocyte, and the Ralph C. Corley Distinguished Professor of Chemistry at Purdue University.
Register for the workshop by Tuesday (March 26), by contacting Sally Ross at email@example.com.
About Purdue Office of Technology Commercialization
The Purdue Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the United States. Services provided by this office support the economic development initiatives of Purdue University and benefit the university's academic activities. In calendar year 2011, Purdue Research Foundation's Office of Technology Commercialization reported 268 invention disclosures, 64 deals finalized, 57 issued U.S. patents, 344 global patents and gross royalty income at $5.8 million. The foundation also reported the creation of nine startup companies in 2011 founded on Purdue innovations.
Media contact: Cynthia Sequin, (765) 588-3340, firstname.lastname@example.orgSource: Hamid Piroozi, HRPiroozi@prf.org